Search research articles
Contact Us
Filters
Showing results (181-190 of 213) with videos related to
Page
of 22
Sort By:
The Journal of Dermatological Treatment
|
October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs
Giulio Gualdi, Laura Bigi, Clara De Simone, et al.
Psoriasis (Auckland, N.Z.)
|
September 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Journal of the American Academy of Dermatology
|
March 3, 2022
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study
Adele Salemme, Luca Fania, Alessandra Scarabello, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
European Journal of Dermatology : EJD
|
March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Andrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Frontiers in Medicine
|
August 7, 2023
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience
Martina Merli, Martina Accorinti, Maurizio Romagnuolo, et al.
Clinical and Experimental Dermatology
|
October 10, 2025
VARIANT_P: a 14-years multicentric follow-up study of atypical pemphigus variants in Italy
Lavinia Quintarelli, Irene Bonanni, Elena Biancamaria Mariotti, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 213) with videos related to
Sort By:
Page
of 22
The Journal of Dermatological Treatment
|
October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs
Giulio Gualdi, Laura Bigi, Clara De Simone, et al.
Psoriasis (Auckland, N.Z.)
|
September 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Journal of the American Academy of Dermatology
|
March 3, 2022
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study
Adele Salemme, Luca Fania, Alessandra Scarabello, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
European Journal of Dermatology : EJD
|
March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Andrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Frontiers in Medicine
|
August 7, 2023
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience
Martina Merli, Martina Accorinti, Maurizio Romagnuolo, et al.
Clinical and Experimental Dermatology
|
October 10, 2025
VARIANT_P: a 14-years multicentric follow-up study of atypical pemphigus variants in Italy
Lavinia Quintarelli, Irene Bonanni, Elena Biancamaria Mariotti, et al.
Page
of 22